// App-Quantinova.ai

37 EP483 : Once-weekly exenatide in a real-world clinical setting: clinical outcomes and analysis of potential predictors of response

Researchers

Presenter

  • Jose Carlos Fernandez-Garcia

Principal Investigators

  • Carmen Maria Cortes-Salazar

  • Isabel Moya-Carmona

  • Ana Maria Gomez-Perez

  • Isabel Cornejo-Pareja

  • Araceli Munoz-Garach

  • Maria Molina-Vega

  • Isabel Mancha Doblas

  • Francisco Tinahones

Medical Centers

  • Pharmacy Department, Virgen de la Victoria University Hospital, Malaga, Spain

  • Pharmacy Department, Virgen de la Victoria University Hospital, Malaga, Spain

  • Badolatosa Primary Care Centre, Seville, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Type 2 diabetes mellitus

Biomarkers

  • Hemoglobin A1c

  • Body mass index

Drug/Treatment

  • Exenatide

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved